VenHub Global Enters Up to $100M Equity Purchase Agreement; Nasdaq Notice

What Happened VenHub Global, Inc. announced on Aug. 26/27, 2026 that it entered an Equity Purchase Agreement with Euphoria Capital that allows the company, at its option during the commitment period, to require the investor to buy up to $100,000,000 of common stock. In connection with the deal the company issued 800,000 “commitment shares” to Euphoria Capital and agreed to file a resale registration statement within 30 days of Aug. 26, 2026. Separately, on Sept. 1, 2026 VenHub received a Nasdaq notice saying its common stock has traded below $1.00 for the last 30 business days and it has 180 days (until Mar. 1, 2027) to regain compliance.

Key Details

• Equity Purchase Agreement effective Aug. 26, 2026 (entered Aug. 27, 2026) with Euphoria Capital; up to $100,000,000 in purchases during the commitment period (up to 24 months).
• Company issued 800,000 commitment shares to the investor; investor may not exceed 4.99% ownership from purchases and holdings.
• Daily put-share limits: the lesser of ($25,000,000 ÷ prior Nasdaq closing price) or 20% of the prior day’s average daily trading volume; purchase price = 97% of the 3‑day average VWAP following the put date.
• The company may not issue put shares in excess of 18,278,571 shares (and investor is not obligated to buy beyond that) until shareholder approval required by Nasdaq Rule 5635(d) is obtained.
• Nasdaq notified the company on Sept. 1, 2026 that it is below the $1 minimum bid price; VenHub has until Mar. 1, 2027 to achieve a $1.00 closing bid for 10 consecutive business days or pursue available cure options (including possible transfer to Nasdaq Capital Market and/or a reverse stock split).

Why It Matters This filing signals a ready source of potential equity funding (up to $100M) that could provide liquidity for operations but also creates dilution risk because shares can be sold into the market under defined limits and at a modest discount (3% below VWAP). The immediate issuance of 800,000 commitment shares is dilution already realized. Separately, the Nasdaq bid‑price notice is a material listing risk: failing to regain a $1 closing bid could lead to delisting, which would likely reduce liquidity and could negatively affect the stock price. Investors should watch share‑count changes, any shareholder votes regarding Nasdaq Rule 5635(d), and the company’s progress on the $1 bid‑price cure.